iPS cell technologies: significance and applications to CNS regeneration and disease.
about
Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord InjuryBiomedical Application of Dental Tissue-Derived Induced Pluripotent Stem CellsUnderstanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patientsApplications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative DiseasesPotential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD)Cell reprogramming and neuronal differentiation applied to neurodegenerative diseases: Focus on Parkinson's diseaseiPS cell transplantation for traumatic spinal cord injuryControlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantationSequential EMT-MET induces neuronal conversion through Sox2.Myogenic differentiation of VCP disease-induced pluripotent stem cells: A novel platform for drug discoveryCreation of a library of induced pluripotent stem cells from Parkinsonian patients.Connectivity and circuitry in a dish versus in a brainReprogramming patient-derived cells to study the epilepsiesRotenone Susceptibility Phenotype in Olfactory Derived Patient Cells as a Model of Idiopathic Parkinson's DiseaseBioengineered Lacrimal Gland Organ Regeneration in Vivo.Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal LineageFyn Kinase regulates GluN2B subunit-dominant NMDA receptors in human induced pluripotent stem cell-derived neurons.Establishment of In Vitro FUS-Associated Familial Amyotrophic Lateral Sclerosis Model Using Human Induced Pluripotent Stem Cells.Cloning and variation of ground state intestinal stem cellsPathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseasesModeling neurological diseases with induced pluripotent cells reprogrammed from immortalized lymphoblastoid cell lines.The silver lining of induced pluripotent stem cell variation.An Integrated Miniature Bioprocessing for Personalized Human Induced Pluripotent Stem Cell Expansion and Differentiation into Neural Stem CellsProteasome impairment in neural cells derived from HMSN-P patient iPSCs.Analysis of induced pluripotent stem cells carrying 22q11.2 deletion.Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC DerivativesStem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?Regenerative medicine for Parkinson's disease.Regenerative therapy for hippocampal degenerative diseases: lessons from preclinical studies.Stem Cells in Neurotoxicology/Developmental Neurotoxicology: Current Scenario and Future Prospects.Traumatic Spinal Cord Injury-Repair and Regeneration.Forced cell cycle exit and modulation of GABAA, CREB, and GSK3β signaling promote functional maturation of induced pluripotent stem cell-derived neurons.Modeling the autistic cell: iPSCs recapitulate developmental principles of syndromic and nonsyndromic ASD.Controlling the Regional Identity of hPSC-Derived Neurons to Uncover Neuronal Subtype Specificity of Neurological Disease Phenotypes.Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.Phenotypic screening with primary neurons to identify drug targets for regeneration and degeneration.In Vivo Reprogramming for CNS Repair: Regenerating Neurons from Endogenous Glial Cells.Myelin repair by transplantation of myelin-forming cells in globoid cell leukodystrophy.Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications.Applications of induced pluripotent stem cell technologies in spinal cord injury.
P2860
Q26748907-248549E3-76DB-4A43-A7F3-3B123258D40CQ26753857-EF83B08E-547D-441D-BF22-939E67FCFFCEQ26784399-63FEC3B4-D785-4BC9-B4AD-A64189755130Q26799331-9E252040-BFCF-4B41-8770-2B76E5702F62Q28077285-C51CF173-7221-4E69-BC47-0B6188B2137BQ28080770-D1BCACFF-1F6F-42A8-862C-C105716DE64EQ28087189-7B902E42-07E5-44D6-BA8E-1EDDAAB18D06Q28543575-01A688E8-ACC5-45B5-A3EE-7B94D6249908Q33742361-9E3A9949-C146-4AE6-A91C-D0996DDF302BQ33757336-AD68D7A1-00C4-4AF7-B3A3-46A5811F0C5DQ33917317-7D4275AC-AFF3-42EE-A623-302AF6445395Q35684598-1CE7C76C-6FB0-4F01-BA1C-7B5FDDA56238Q35789597-F5B3156C-FD9D-479E-BE97-F144EB372545Q36001692-704890B4-D356-4E48-9138-CDF4DBA46A32Q36138820-6E22D6D3-CA69-4016-8F24-D2E285EE8E03Q36702988-2B86B9FF-090B-4E53-9968-5E34EE196196Q36760607-18AA48BE-43E2-491A-957D-9B44DC895D1DQ36805034-451F6E5F-77C1-40DB-B114-5D0951BA0A26Q36860891-6739A7CD-8E9A-42CA-9BF4-D209A19FA206Q37264786-1761393B-65CA-42D3-8E68-2EC51003D670Q37304493-C889C022-976D-4C18-8D69-774C813A7E7EQ37531034-8E53D8C7-FDD0-4D6B-8F54-3131B5004ADAQ37563507-9024639F-805D-4600-88E4-4ECB0C437BD9Q37642955-D4BF0E6D-4331-4F81-A44F-ACE2CCB89558Q37648244-3CB571F4-FD7E-4441-996F-7C228C6F2C97Q37707825-B2ECE7A0-0BA3-4DA6-B4A6-31D1C2DE1040Q38341972-2DA87308-C553-4D26-B1FD-62BD1B0454CAQ38369065-0E1B4C01-E04A-4D71-920B-A2671FB330D3Q38539382-8C68FF89-8C52-4D7B-8230-EB845A7E2340Q38669057-595EAE95-D4AD-4B4B-8AFD-7424C951C51AQ38738492-C7910D07-AD5D-4AD1-8FBC-2F127D1BA5E0Q38807798-370A6433-F2AD-400E-861C-50D136FB882AQ38816786-50CC5576-542F-408F-AB34-0C2BF01C8497Q38820880-B90FEA78-365D-4DAD-AEA5-FFFFBC405F35Q38834545-236DCA21-7E60-42A2-8C2C-9A97557B7AC4Q38904862-7C568A6C-C38F-4D7C-A4A2-136EED55D289Q38930831-0022FF97-6A05-4170-918F-B804FEB2EAFFQ38936382-8CC5D724-F5C7-45F6-9E82-A471B1C03597Q38945910-959021B0-A6E0-495E-9642-89BD232F6E80Q39136445-49C58D44-3C89-48DC-8B9C-77822CE3D968
P2860
iPS cell technologies: significance and applications to CNS regeneration and disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
iPS cell technologies: significance and applications to CNS regeneration and disease.
@en
iPS cell technologies: significance and applications to CNS regeneration and disease.
@nl
type
label
iPS cell technologies: significance and applications to CNS regeneration and disease.
@en
iPS cell technologies: significance and applications to CNS regeneration and disease.
@nl
prefLabel
iPS cell technologies: significance and applications to CNS regeneration and disease.
@en
iPS cell technologies: significance and applications to CNS regeneration and disease.
@nl
P2860
P921
P356
P1433
P1476
iPS cell technologies: significance and applications to CNS regeneration and disease.
@en
P2860
P2888
P356
10.1186/1756-6606-7-22
P5008
P577
2014-03-31T00:00:00Z
P5875
P6179
1003207022